IsoPlexis
is a Connecticut-based single-cell detection platform that provides solutions including predicting disease progression and treatment resistance for researchers... Read moreIsoPlexis
is a Connecticut-based single-cell detection platform that provides solutions including predicting disease progression and treatment resistance for researchers... Read more
2012
PrivateAcquired by PhenomeX Inc.
News
Mar 27, 2025
IsoPlexis Blog
IsoPlexis Blog Pushing the Boundaries in Cell Line Development: Webinar Recap
Mar 17, 2025
IsoPlexis Blog
IsoPlexis Blog Efficiently Generating and Selecting Broadly Neutralizing Antibodies with Mosaic Nanoparticle Immunization and Multiplexed Screening
Mar 04, 2025
IsoPlexis Blog
IsoPlexis Blog AI Needs More Than Sequences to Cure Cancer - It Needs Sequence Data Linked to Functional Outcomes
Feb 18, 2025
IsoPlexis Blog
IsoPlexis Blog Recent Advancements in Therapeutic Antibody Discovery: Bispecific Antibodies, ADCs, Fully Human Antibodies, and Technology Driving Antibody Discovery Forward
Jan 30, 2025
IsoPlexis Blog
IsoPlexis Blog T Cell Research Trends: Breakthroughs in Immunotherapy and Cancer Treatment
Nov 09, 2024
IsoPlexis Blog
IsoPlexis Blog Protected: Accelerating the Cell Line Development Timeline: How to Deliver Lead Clones in Six Weeks
Sep 20, 2024
IsoPlexis Blog
IsoPlexis Blog Revolutionizing Bispecific Antibody Production Using the Beacon Platform
Aug 27, 2024
IsoPlexis Blog
IsoPlexis Blog Efficiency with Excellence: Expedite Cell Line Development Timelines with the Beacon Platform's Selective Cell Cloning
Apr 12, 2024
IsoPlexis Blog
IsoPlexis Blog Unlocking Insights in Antibody Discovery: An Integrated Approach with the Beacon Platform and PipeBio
Apr 05, 2024
IsoPlexis Blog
IsoPlexis Blog Application Note: Revolutionizing Adoptive Cell Therapy Development with Bruker's Beacon Platform
IsoPlexis Competitors
1
2
3
4
5
6
7
8
9
10